These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 6874629)

  • 1. The fractional inhibitory concentration (FIC) index as a measure of synergy.
    Hall MJ; Middleton RF; Westmacott D
    J Antimicrob Chemother; 1983 May; 11(5):427-33. PubMed ID: 6874629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial properties of alafosfalin combined with cephalexin.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Nisbet LJ; Ringrose PS; Westmacott D
    Antimicrob Agents Chemother; 1981 Oct; 20(4):470-6. PubMed ID: 7044291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro potentiation of cephalosporins by alafosfalin against urinary tract bacteria.
    Arisawa M; Ohshima J; Ohsawa E; Maruyama HB
    Antimicrob Agents Chemother; 1982 May; 21(5):706-10. PubMed ID: 7103452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alafosfalin, a new inhibitor of cell wall biosynthesis: in vitro activity against urinary isolates in Japan and potentiation with beta-lactams.
    Maruyama HB; Arisawa M; Sawada T
    Antimicrob Agents Chemother; 1979 Oct; 16(4):444-51. PubMed ID: 518073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of sophoraflavanone G isolated from the roots of Sophora flavescens.
    Cha JD; Jeong MR; Jeong SI; Lee KY
    J Microbiol Biotechnol; 2007 May; 17(5):858-64. PubMed ID: 18051310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro effects of sulbactam combinations with different antibiotic groups against clinical Acinetobacter baumannii isolates.
    Deveci A; Coban AY; Acicbe O; Tanyel E; Yaman G; Durupinar B
    J Chemother; 2012 Oct; 24(5):247-52. PubMed ID: 23182043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro studies as supporting evidence on the efficacy of antimicrobials for mastitis treatment.
    Pyörälä S
    J Appl Microbiol; 2009 Dec; 107(6):2116-7. PubMed ID: 19811570
    [No Abstract]   [Full Text] [Related]  

  • 8. Antimicrobial properties of methdilazine and its synergism with antibiotics and some chemotherapeutic agents.
    Chattopadhyay D; Dastidar SG; Chakrabarty AN
    Arzneimittelforschung; 1988 Jul; 38(7):869-72. PubMed ID: 2905130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alafosfalin, a new synthetic antibacterial compound.
    Hahn FE
    Naturwissenschaften; 1981 Feb; 68(2):90. PubMed ID: 7219565
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of natural antimicrobials to increase antibiotic susceptibility of drug resistant bacteria.
    Palaniappan K; Holley RA
    Int J Food Microbiol; 2010 Jun; 140(2-3):164-8. PubMed ID: 20457472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In-vitro activity of imipenem combined with beta-lactam antibiotics for methicillin-resistant Staphylococcus aureus.
    Matsuda K; Asahi Y; Sanada M; Nakagawa S; Tanaka N; Inoue M
    J Antimicrob Chemother; 1991 Jun; 27(6):809-15. PubMed ID: 1938687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental studies on synergism between aminoglycosides and the antimicrobial antiinflammatory agent diclofenac sodium.
    Annadurai S; Guha-Thakurta A; Sa B; Dastidar SG; Ray R; Chakrabarty AN
    J Chemother; 2002 Feb; 14(1):47-53. PubMed ID: 11892899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial activity of phosphono dipeptides related to alafosfalin.
    Lejczak B; Kafarski P; Sztajer H; Mastalerz P
    J Med Chem; 1986 Nov; 29(11):2212-7. PubMed ID: 3783584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of azithromycin in combination with amikacin, ceftazidime, ciprofloxacin or imipenem against clinical isolates of Acinobacter baumannii.
    Fernández-Cuenca F; Martínez-Martínez L; Pascual A; Perea EJ
    Chemotherapy; 2003 May; 49(1-2):24-6. PubMed ID: 12714805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interaction of aminoglycosides and the other antibiotic on selected bacterial strains].
    Grzybowska W; Banaszczyk-Ruś M; Tyski S
    Med Dosw Mikrobiol; 2004; 56(3):275-85. PubMed ID: 15773504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new powerful antibacterial synergistic combination of trimethoprim and trimeprazine.
    Guha Thakurta A; Mandal SK; Ganguly K; Dastidar SG; Chakrabarty AN
    Acta Microbiol Immunol Hung; 2000; 47(1):21-8. PubMed ID: 10735187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergy of flavone with vancomycin and oxacillin against vancomycin-intermediate Staphyloccus aureus.
    Bakar NS; Zin NM; Basri DF
    Pak J Pharm Sci; 2012 Jul; 25(3):633-8. PubMed ID: 22713953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of aminoglycosides and cephalosporins against Pseudomonas aeruginosa. Correlation between interaction index and killing curve.
    Perea EJ; Clavijo E; Nogales MC; García Luque IG
    J Antimicrob Chemother; 1988 Aug; 22(2):175-83. PubMed ID: 3141342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphonopeptide antibacterial agents related to alafosfalin: design, synthesis, and structure-activity relationships.
    Atherton FR; Hall MJ; Hassall CH; Holmes SW; Lambert RW; Lloyd WJ; Ringrose PS
    Antimicrob Agents Chemother; 1980 Dec; 18(6):897-905. PubMed ID: 7016027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Do different interpretative methods used for evaluation of checkerboard synergy test affect the results?].
    Ozseven AG; Sesli Çetin E; Ozseven L
    Mikrobiyol Bul; 2012 Jul; 46(3):410-20. PubMed ID: 22951653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.